Awarded contract

Live Attenuated Influenza vaccine 2026/2027

Details

Buyer: UK Health Security Agency
Supplier(s): Astra Zeneca UK Limited
Value: £225,408,000
Duration: 2 years
Topic: Influenza vaccines
Published: 19 June 2026
Source: uk:contracts_finder

Tender description

For the supply of Live Attenuated Influenza vaccine 2026/2027

Timeline

Completed: Award published19 June 2026
Current notice
Completed: Award date1 August 2026
Next: Contract expiry date31 July 2028in 2 years

About the buyer

The UK Health Security Agency (UKHSA) is an executive agency sponsored by the Department of Health and Social Care, and buys through its own end-to-end commercial service. Procurement, contract management and market engagement sit within the Commercial, Vaccines and Countermeasures Delivery directorate. Contracts are tendered under UK procurement legislation that ensures open and fair competition between bidders. Suppliers register on the UKHSA eTendering Portal to take part. UKHSA hosts the Diagnostics and Research Open Framework for diagnostics and research supplies and services. A published pipeline lists larger planned commercial activity.

Procurement spend from central entities makes up 66% of overall UK public spend.

Over the past 5 years, most of UK Health Security Agency's contract awards have been in medical equipment and pharmaceuticals, laboratory and precision equipment and software and information systems.

Relevant CPV codes

33651660 · Influenza vaccines

Decision makers

Connect with the people behind this procurement.

Job title	Phone number	Work email
Head of Procurement	+44 •••• ••••••	••••••••@uk-health-security-agency.gov
Commercial Director	+44 •••• ••••••	••••••••@uk-health-security-agency.gov
Procurement Manager	+44 •••• ••••••	••••••••@uk-health-security-agency.gov
Category Lead	+44 •••• ••••••	••••••••@uk-health-security-agency.gov
Senior Buyer	+44 •••• ••••••	••••••••@uk-health-security-agency.gov
Contracts Manager	+44 •••• ••••••	••••••••@uk-health-security-agency.gov